T
Thanyawee Puthanakit
Researcher at Chulalongkorn University
Publications - 269
Citations - 4759
Thanyawee Puthanakit is an academic researcher from Chulalongkorn University. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 33, co-authored 222 publications receiving 3762 citations. Previous affiliations of Thanyawee Puthanakit include Institut de recherche pour le développement & Center for Excellence in Education.
Papers
More filters
Journal ArticleDOI
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B
Gonzague Jourdain,Nicole Ngo-Giang-Huong,Linda Harrison,Luc Decker,Woottichai Khamduang,Camlin Tierney,Nicolas Salvadori,Tim R. Cressey,Wasna Sirirungsi,Jullapong Achalapong,Prapap Yuthavisuthi,Prateep Kanjanavikai,Orada P. Na Ayudhaya,Thitiporn Siriwachirachai,Sinart Prommas,Prapan Sabsanong,Aram Limtrakul,Supang Varadisai,Chaiwat Putiyanun,Pornnapa Suriyachai,Prateung Liampongsabuddhi,Suraphan Sangsawang,Wanmanee Matanasarawut,Sudanee Buranabanjasatean,Pichit Puernngooluerm,Chureeratana Bowonwatanuwong,Thanyawee Puthanakit,Virat Klinbuayaem,Satawat Thongsawat,Sombat Thanprasertsuk,George K. Siberry,D. H. Watts,Nahida Chakhtoura,Trudy V. Murphy,Noele P. Nelson,Raymond T. Chung,Stanislas Pol,Nantasak Chotivanich +37 more
TL;DR: In a setting in which the rate of mother‐to‐child HBV transmission was low with the administration of hepatitis B immune globulin and hepatitis B vaccine in infants born to HBeAg‐positive mothers, the additional maternal use of TDF did not result in a significantly lower rate of transmission.
Journal ArticleDOI
Efficacy of Highly Active Antiretroviral Therapy in HIV-Infected Children Participating in Thailand's National Access to Antiretroviral Program
Thanyawee Puthanakit,Aurmporn Oberdorfer,Noppadon Akarathum,Suparat Kanjanavanit,Pornphun Wannarit,Thira Sirisanthana,Virat Sirisanthana +6 more
TL;DR: In this resource-limited setting, HAART is safe and effective for HIV-infected children despite initiation of treatment during the advanced stage of disease.
Journal ArticleDOI
Federated learning for predicting clinical outcomes in patients with COVID-19.
Ittai Dayan,Holger R. Roth,Aoxiao Zhong,Ahmed Harouni,Amilcare Gentili,Anas Z. Abidin,Andrew Liu,Anthony Costa,Bradford J. Wood,Chien-Sung Tsai,Chih-Hung Wang,Chun-Nan Hsu,C. K. Lee,Peiying Ruan,Daguang Xu,Dufan Wu,Eddie Huang,Felipe Kitamura,Griffin Lacey,Gustavo César de Antônio Corradi,Gustavo Nino,Hao-Hsin Shin,Hirofumi Obinata,Hui Ren,Jason C. Crane,Jesse Tetreault,Jiahui Guan,John Garrett,Joshua D. Kaggie,Jung Gil Park,Keith J. Dreyer,Krishna Juluru,Kristopher Kersten,Marcio Aloisio Bezerra Cavalcanti Rockenbach,Marius George Linguraru,Marius George Linguraru,Masoom A. Haider,Masoom A. Haider,Meena AbdelMaseeh,Nicola Rieke,Pablo F. Damasceno,Pedro Mário Cruz e Silva,Pochuan Wang,Sheng Xu,Shuichi Kawano,Sira Sriswasdi,Soo-Young Park,Thomas M. Grist,Varun Buch,Watsamon Jantarabenjakul,Watsamon Jantarabenjakul,Weichung Wang,Won Young Tak,Xiang Li,Xihong Lin,Young Joon Kwon,Abood Quraini,Andrew Feng,Andrew N. Priest,Baris Turkbey,Benjamin S. Glicksberg,Bernardo Bizzo,Byung Seok Kim,Carlos Tor-Díez,Chia-Cheng Lee,Chia-Jung Hsu,Chin Lin,Chiu-Ling Lai,Christopher P. Hess,Colin B. Compas,Deepeksha Bhatia,Eric K. Oermann,Evan Leibovitz,Hisashi Sasaki,Hitoshi Mori,Isaac Yang,Jae Ho Sohn,Krishna Nand Keshava Murthy,Li-Chen Fu,Matheus Ribeiro Furtado de Mendonça,Mike Fralick,Min Kyu Kang,Mohammad Adil,Natalie Gangai,Peerapon Vateekul,Pierre Elnajjar,Sarah E Hickman,Sharmila Majumdar,Shelley McLeod,Sheridan Reed,Stefan Gräf,Stephanie Harmon,Tatsuya Kodama,Thanyawee Puthanakit,Thanyawee Puthanakit,Tony Mazzulli,Tony Mazzulli,Vitor Lavor,Yothin Rakvongthai,Yu Rim Lee,Yuhong Wen,Fiona J. Gilbert,Mona Flores,Quanzheng Li +103 more
TL;DR: In this article, the authors used federated learning to predict future oxygen requirements of symptomatic patients with COVID-19 using inputs of vital signs, laboratory data and chest X-rays.
Journal ArticleDOI
Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children
Thanyawee Puthanakit,Peninnah Oberdorfer,Noppadon Akarathum,Pornphun Wannarit,Thira Sirisanthana,Virat Sirisanthana +5 more
TL;DR: IRS is common among HIV-infected children who received HAART in their advanced stage of disease and educational programs for patients and health care workers on recognizing and treating these conditions should be integrated into antiretroviral treatment access programs.
Journal ArticleDOI
Cognitive Function and Neurodevelopmental Outcomes in HIV-Infected Children Older than 1 Year of Age Randomized to Early Versus Deferred Antiretroviral Therapy: The PREDICT Neurodevelopmental Study
Thanyawee Puthanakit,Jintanat Ananworanich,Saphonn Vonthanak,Pope Kosalaraksa,Rawiwan Hansudewechakul,Jasper van der Lugt,Stephen J. Kerr,Suparat Kanjanavanit,Chaiwat Ngampiyaskul,Jurai Wongsawat,Wicharn Luesomboon,Ung Vibol,Kanchana Pruksakaew,Tulathip Suwarnlerk,Tanakorn Apornpong,Kattiya Ratanadilok,Robert H. Paul,Lynne M. Mofenson,Lawrence Fox,Victor Valcour,Pim Brouwers,Kiat Ruxrungtham +21 more
TL;DR: In HIV-infected children surviving beyond 1 year of age without ART, neurodevelopmental outcomes were similar with ART initiation at CD4 15%–24% versus <15%, but both groups performed worse than HIV-un infected children.